Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

FDA informs Urologix of new developments concerning the Targis System

Jan. 6, 2000

Injectable levocarnitine approved for use in dialysis in U.S.

Dec. 28, 1999

Once-daily oxybutynin assessed in urinary urge incontinence

Dec. 27, 1999

Vivus seeks FDA approval for new impotence drug

Dec. 23, 1999

Vasomax progress updated by Zonagen

Dec. 22, 1999

NexMed initiates phase II trials of alprostadil cream in U.S.

Dec. 22, 1999

Milestone for Gene Logic in kidney disease collaboration

Dec. 21, 1999

Herbomineral preparation shows efficacy in animal model of BPH

Dec. 15, 1999

SS-cream increases ejaculatory latency and satisfaction in patients with premature ejaculation

Dec. 14, 1999

Quark Biotech, Taisho investigate new treatments for renal disease

Dec. 14, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...